Table 2.
Adverse events within 14 days after vaccination.
| 1st dose |
2nd dose |
||||
|---|---|---|---|---|---|
| n = 2,406 | (%) | n = 2,347 | (%) | P value | |
| Any adverse events | 2,134 | (88.7) | 2,168 | (92.4) | <0.01 |
| Mild | 1,505 | (62.6) | 1,008 | (42.9) | <0.01 |
| Moderate | 601 | (25.0) | 1,003 | (42.7) | |
| Severe | 27 | (1.1) | 154 | (6.6) | |
| Pain at injection site | 1,706 | (70.9) | 1,811 | (77.2) | <0.01 |
| Myalgia | 1,112 | (46.2) | 1,378 | (58.7) | <0.01 |
| Fatigue | 565 | (23.5) | 1,407 | (59.9) | <0.01 |
| Headache | 485 | (20.2) | 1,159 | (49.4) | <0.01 |
| Induration at injection site | 307 | (12.8) | 402 | (17.1) | <0.01 |
| Joint pain | 274 | (11.4) | 1,003 | (42.7) | <0.01 |
| Chillness | 140 | (5.8) | 983 | (41.9) | <0.01 |
| Erythema at injection site | 92 | (3.8) | 194 | (8.3) | <0.01 |
| Nausea | 85 | (3.5) | 229 | (9.8) | <0.01 |
| Fever ≥ 37.5 °C | 11 | (0.5) | 231 | (9.8) | <0.01 |
| Clinic visit | 9 | (0.4) | 13 | (0.6) | 0.40 |